News
Acetaminophen: A Viable Alternative for ... Available without prescription and with fewer side effects than ... (22 Jun 2017)
Flights can make aircrew sick, Stirling ... Flying a plane should come with a health warning, according to ... (22 Jun 2017)
Study uncovers link between male hormones ... Scientists from the University of Birmingham have discovered the ... (22 Jun 2017)
Does Roasting Level Affect the Antioxidant ... Researchers compared the caffeine and chlorogenic acid ... (22 Jun 2017)
Breast implants may impede ECG and lead to ... Breast implants may impede an electrocardiogram (ECG) and could ... (21 Jun 2017)
Monday, 12 June 2017 12:59

Metastasised breast cancer: Surgery prior to drug treatment not beneficial Featured

Rate this item
(0 votes)

A new study from the ABCSG (Austrian Breast & Colorectal Cancer Study Group) indicates that women suffering from metastasised breast cancer do not benefit from surgery performed prior to drug treatment. This could cause a paradigm shift in treatment of the disease.

breast canceropThe multi-centre trial, conducted under the direction of Florian Fitzal, was presented this weekend at the ASCO meeting, one of the most important international cancer conferences. Florian Fitzal is Head of Breast Surgery at the Department of Surgery of MedUni Vienna/Vienna General Hospital and one of the two deputy heads of the Breast Health Center at the Comprehensive Cancer Centre (CCC) of MedUni Vienna and Vienna General Hospital.

In Austria, around 250 women a year are told they are suffering from primary "metastatic breast cancer". That means: breast cancer is first diagnosed at a late stage. Despite recent advances in treatment, a "cure" is not possible in these fortunately rare situations; the therapeutic aims are to maintain quality-of-life and extend life expectancy – many women go on to survive for several years. Breast cancer experts from throughout the world are therefore working to improve treatment strategies and, at the same time, the quality-of-life of their patients.

Paradigm shift

A research team from the ABCSG (President: Michael Gnant, MedUni Vienna/Vienna General Hospital), headed up by Florian Fitzal, therefore explored whether immediate surgical removal of the breast cancer tissue prior to administration of systemic (drug) therapy influences the treatment outcome. During the last decade, this method was regarded as a possible strategy for treating primary metastatic breast cancer. The scientific basis for this procedure was retrospective studies, that is to say studies that analyse pre-existing data, and these showed that surgery could potentially prolong survival by up to 50%.

The results of the ABCSG-28 trial now show that surgery prior to systemic therapy does not improve the outcome over primary systemic therapy. These results tally with the findings of other international studies that have recently appeared.

Says Fitzal: "Our work shows that an operation does not offer patients any advantage in terms of survival. This means that, in the interests of giving them better quality-of-life, many of them could be spared this stressful procedure. This could cause a paradigm shift in the treatment of primary metastatic breast cancer."


Source: Medical University of Vienna

Bibliographic information:
“Primary operation in synchroneous metastasized invasive breast cancer patients: first oncologic outcomes of the prospective randomized phase III ABCSG 28 POSYTIVE trial”

Read 111 times

TheSynapse Videos

0
0
0
0
0
0

Latest news

Links

Join

Connect with other Medical Professionals on fb in a closed facebook group

Login

Template Settings

Theme Colors

Cyan Red Green Oranges Teal

Layout

Wide Boxed Framed Rounded
Patterns for Layour: Boxed, Framed, Rounded
Top
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…